Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer. [electronic resource]
Producer: 20201204Description: 589-597 p. digitalISSN:- 1439-099X
- Adenocarcinoma -- drug therapy
- Anastrozole -- therapeutic use
- Androgen Antagonists -- adverse effects
- Androgens
- Anilides -- adverse effects
- Antineoplastic Agents, Hormonal -- adverse effects
- Dizziness -- chemically induced
- Dose Fractionation, Radiation
- Drug Administration Schedule
- Estrogen Receptor Modulators -- administration & dosage
- Flushing -- chemically induced
- Gynecomastia -- chemically induced
- Humans
- Male
- Mastodynia -- chemically induced
- Meta-Analysis as Topic
- Neoplasms, Hormone-Dependent -- drug therapy
- Nitriles -- adverse effects
- Off-Label Use
- Prostatic Neoplasms -- drug therapy
- Randomized Controlled Trials as Topic
- Tamoxifen -- administration & dosage
- Tosyl Compounds -- adverse effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.